We use cookies for a better user experience. Read our Privacy Policy
I Agree
Apheresis Market Trends, 2017-2025
According to the professional survey report by the Transparency Market Research, the global apheresis market was evaluated at US$ 1.85 billion at the beginning of the forecast period i.e. in 2016 and is likely to expand to reach the valuation of 4.33 billion at the end of the forecast period i.e. in 2025. The research report also predicts that the global apheresis market will record a noteworthy growth rate of 10.2 % during the forecast period i.e. 2017 to 2025. Some of the key drivers for the global apheresis market include rising applications of apheresis procedures in numerous neurological, cardiovascular, autoimmune, renal, and hematological applications.
Furthermore, the advancements in the medical technologies as well as the increasing popularity and population participation in blood donation drives and camps is anticipated to bolster the demand within the global apheresis market in coming years. The types of products offered by the vendors and players operational within the global apheresis market are disposable as well as devices. Some of the leading applications for the solutions and products within the global apheresis market include neurology, cancer, cardiovascular diseases, diabetes, renal diseases, hematology, autoimmune diseases, and fibrosis, among others.
The segments in the global apheresis market classified by the type of procedure include photopheresis, plateletpheresis, erythrocytapheresis, extracorporeal immunoadsorption, plasmapheresis, LDL apheresis, leukapheresis, and lymphapheresis, among others. Among these, the photopheresis procedure segment is likely to dominate the global apheresis market in terms of growth, recording approximately 12.2 % growth within the forecast years. The segment of plasmapheresis led the global apheresis market in 2016, owing to the numerous applications of these procedures in plasma exchange in therapeutic processes.
Segments in the global apheresis market classified on the basis of technology used are membrane filtration technologies as well as centrifugation technologies. Some of the most prominent end users for the products and solutions offered by the players in the global apheresis market include blood collection centers, private, hospitals, and public.
Key regions covered in the business intelligence report on the global apheresis market are North America, Middle East and Africa, Europe, Latin America, and Asia Pacific. Among these, North America region led the global apheresis market in 2016, owing to the rising demand for plasma, intended for the production of medicines derived from plasma as well as the presence of well-trenched healthcare and medical infrastructure in the region. However, another region that is set to experience outstanding growth within the global apheresis market in coming years is Asia Pacific. The report predicts that the Asia Pacific region will record a substantial growth rate of 11.2 % in the global apheresis market over the forecast period.
Key trends influencing the demand dynamics within the Asia Pacific region in global apheresis market include increasing prevalence of various chronic diseases and health conditions, increase in the elderly regional population, and rising spending on medical and healthcare industries. Furthermore, the presence of substantial industry bases of global apheresis market in regional economies, such as China and India is also expected to foster the development of the Asia Pacific region in the global apheresis market in near future.
Some of the leading incumbent players and vendors working within the global apheresis market are Terumo Corporation, Fresenius Kabi AG, B. Braun Melsungen AG, NIKKISO Co., Ltd., Medica S. p. A., Asahi Kasei Medical Co. Ltd., Haemonetics Corporation, Cerus Corporation, Kawasumi Laboratories, Inc., and Therakos, Inc., among others.
The global apheresis market has been segmented as follows:
|
by Product Type |
|
|
by Application |
|
|
by Procedure |
|
|
by Technology |
|
|
by End-User |
|
|
by Geography |
|
Apheresis Market is projected to reach a value of US$4.33 billion by the end of 2025
Apheresis Market is expected to grow at a CAGR of 10.20% during the forecast period
Apheresis Market is driven by rising applications of apheresis procedures in numerous neurological, cardiovascular, autoimmune, renal, and hematological applications
The photopheresis procedure segment is likely to dominate the global apheresis market within the forecast years
Top key players in apheresis market are Medica S.p.A., Fresenius Kabi AG, Therakos, Inc., Kawasumi Laboratories Inc., Asahi Kasei Medical Co. Ltd., Terumo Corporation, NIKKISO CO., LTD., B. Braun Melsungen AG, Haemonetics Corporation, and Cerus Corporation
1.Preface
1.1.Market Definition and Scope
1.2.Market Segmentation
1.3.Key Research Objectives
1.4.Research Highlights
2.Assumptions and Research Methodology
3.Executive Summary
4.Market Definition
4.1.Introduction
4.1.1.Product/Service Definition
4.1.2.Industry Evolution / Developments
4.2.Market Overview
4.3.Key Market Indicators
4.3.1.Global Health Care Expenditure Scenario
4.4.Market Dynamics
4.4.1.Drivers
4.4.2.Restraints
4.4.3.Opportunities
4.5.Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast, 2016 – 2024
4.5.1.Market Revenue Projections (US$ Mn)
4.6.Apheresis Market (Therapeutic Apheresis & Donor Apheresis) - Global Supply Demand Scenario
4.7.Porter’s Five Force Analysis
4.8.Event Impact Analysis
4.9.Market Outlook
5.Global Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecasts, By Product Type
5.1.Introduction & Definition
5.2.Key Findings / Developments
5.3.Key Trends
5.4. Market Size (US$ Mn) Forecast By Product Type
5.4.1.Devices
5.4.2.Disposables
5.5. Market Attractiveness By Product Type
6.Global Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast, By Application
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Key Trends
6.4. Market Size (US$ Mn) Forecast, By Application
6.4.1.Renal diseases
6.4.2.Neurology
6.4.3.Hematology
6.4.4.Cancer
6.4.5.Autoimmune disease
6.4.6.Cardiovascular diseases
6.4.7.Others (e.g. Fibrosis, Diabetes, Dermatology etc.)
6.5. Comparison Matrix
6.6. Market Attractiveness By Application
7.Global Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecasts, By Procedure
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Key Trends
7.4. Market Size (US$ Mn) Forecast By Procedure
7.4.1.Plasmapheresis
7.4.2.Photopheresis
7.4.3.LDL-apheresis
7.4.4.Plateletpheresis
7.4.5.Leukapheresis
7.4.6.Erythrocytapheresis
7.4.7.Others (e.g. lymphapheresis, extracorporeal immunoadsorption, etc.)
7.5. Comparison Matrix
7.6. Market Attractiveness By Procedure
8.Global Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecasts, By Technology
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Key Trends
8.4. Market Size (US$ Mn) Forecast By Technology
8.4.1.Centrifugation
8.4.2.Membrane filtration
8.5. Comparison Matrix
8.6. Market Attractiveness By Technology
9.Global Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecasts, By End-User
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Key Trends
9.4. Market Size (US$ Mn) Forecast By End-User
9.4.1. Hospitals
9.4.2. Blood Collection Centers
9.4.2.1.Public
9.4.2.2.private
9.5. Comparison Matrix
9.6. Market Attractiveness By End-User
10.Global Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecasts, By Region
10.1. Key Findings
10.2. Policies and Regulations
10.3. Market Size (US$ Mn) Forecast By Region
10.3.1. North America
10.3.2. Europe
10.3.3. Asia Pacific
10.3.4. Latin America
10.3.5. Middle East & Africa
10.4. Market Attractiveness By Country/Region
11.North America Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast
11.1. Introduction & Definition
11.2. Key Findings / Developments
11.3. Key Trends
11.4. Market Size (US$ Mn) Forecast, By Country
11.4.1. U.S.
11.4.2. Canada
11.5. Market Size (US$ Mn) Forecast By Product Type
11.5.1. Devices
11.5.2.Disposables
11.6. Market Size (US$ Mn) Forecast, By Application
11.6.1. Renal diseases
11.6.2. Neurology
11.6.3. Hematology
11.6.4. Cancer
11.6.5. Autoimmune disease
11.6.6. Cardiovascular diseases
11.6.7. Others
11.7. Market Size (US$ Mn) Forecast By Procedure
11.7.1. Plasmapheresis
11.7.2. Photopheresis
11.7.3. LDL-apheresis
11.7.4. Plateletpheresis
11.7.5. Leukapheresis
11.7.6. Erythrocytapheresis
11.7.7. Others
11.8. Market Size (US$ Mn) Forecast, By Technology
11.8.1. Centrifugation
11.8.2. Membrane filtration
11.9. Market Size (US$ Mn) Forecast, By End User
11.9.1.Hospitals
11.9.2.Blood Collection Centers
11.9.2.1.Public
11.9.2.2.private
11.10. Market Attractiveness Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Procedure
11.10.5. By Technology
11.10.6. By End User
12.Europe Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast
12.1. Introduction & Definition
12.2. Key Findings / Developments
12.3. Key Trends
12.4. Market Size (US$ Mn) Forecast, By Country
12.4.1. Germany
12.4.2. France
12.4.3. U.K.
12.4.4. Italy
12.4.5. Spain
12.4.6. Rest of Europe
12.5. Market Size (US$ Mn) Forecast By Product Type
12.5.1. Devices
12.5.2.Disposables
12.6. Market Size (US$ Mn) Forecast, By Application
12.6.1. Renal diseases
12.6.2. Neurology
12.6.3. Hematology
12.6.4. Cancer
12.6.5. Autoimmune disease
12.6.6. Cardiovascular diseases
12.6.7. Others
12.7. Market Size (US$ Mn) Forecast By Procedure
12.7.1. Plasmapheresis
12.7.2. Photopheresis
12.7.3. LDL apheresis
12.7.4. Plateletpheresis
12.7.5. Leukapheresis
12.7.6. Erythrocytapheresis
12.7.7. Others
12.8. Market Size (US$ Mn) Forecast, By Technology
12.8.1. Centrifugation
12.8.2. Membrane filtration
12.9. Market Size (US$ Mn) Forecast, By End User
12.9.1.Hospitals
12.9.2.Blood Collection Centers
12.9.2.1.Public
12.9.2.2.private
12.10. Market Attractiveness Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Procedure
12.10.5. By Technology
12.10.6. By End User
13.Asia Pacific Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast
13.1. Introduction & Definition
13.2. Key Findings / Developments
13.3. Key Trends
13.4. Market Size (US$ Mn) Forecast, By Country
13.4.1. Japan
13.4.2. China
13.4.3. India
13.4.4. Australia
13.4.5. Rest of Asia Pacific
13.5. Market Size (US$ Mn) Forecast By Product Type
13.5.1. Devices
13.5.2.Disposables
13.6. Market Size (US$ Mn) Forecast, By Application
13.6.1. Renal diseases
13.6.2. Neurology
13.6.3. Hematology
13.6.4. Cancer
13.6.5. Autoimmune disease
13.6.6. Cardiovascular diseases
13.6.7. Others
13.7. Market Size (US$ Mn) Forecast By Procedure
13.7.1. Plasmapheresis
13.7.2. Photopheresis
13.7.3. LDL-apheresis
13.7.4. Plateletpheresis
13.7.5. Leukapheresis
13.7.6. Erythrocytapheresis
13.7.7. Others
13.8. Market Size (US$ Mn) Forecast, By Technology
13.8.1. Centrifugation
13.8.2. Membrane filtration
13.9. Market Size (US$ Mn) Forecast, By End User
13.9.1.Hospitals
13.9.2.Blood Collection Centers
13.9.2.1.Public
13.9.2.2.private
13.10. Market Attractiveness Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Procedure
13.10.5. By Technology
13.10.6. By End User
14.Latin America Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast
14.1. Introduction & Definition
14.2. Key Findings / Developments
14.3. Key Trends
14.4. Market Size (US$ Mn) Forecast, By Country
14.4.1. Brazil
14.4.2. Mexico
14.4.3. Rest of Latin America
14.5. Market Size (US$ Mn) Forecast By Product Type
14.5.1. Devices
14.5.2.Disposables
14.6. Market Size (US$ Mn) Forecast, By Application
14.6.1. Renal diseases
14.6.2. Neurology
14.6.3. Hematology
14.6.4. Cancer
14.6.5. Autoimmune disease
14.6.6. Cardiovascular diseases
14.6.7. Others
14.7. Market Size (US$ Mn) Forecast By Procedure
14.7.1. Plasmapheresis
14.7.2. Photopheresis
14.7.3. LDL-apheresis
14.7.4. Plateletpheresis
14.7.5. Leukapheresis
14.7.6. Erythrocytapheresis
14.7.7. Others
14.8. Market Size (US$ Mn) Forecast, By Technology
14.8.1. Centrifugation
14.8.2. Membrane filtration
14.9. Market Size (US$ Mn) Forecast, By End User
14.9.1.Hospitals
14.9.2.Blood Collection Centers
14.9.2.1.Public
14.9.2.2.private
14.10. Market Attractiveness Analysis
14.10.1. By Country
14.10.2. By Product Type
14.10.3. By Application
14.10.4. By Procedure
14.10.5. By Technology
14.10.6. By End User
15.Middle East & Africa Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast
15.1. Introduction & Definition
15.2. Key Findings / Developments
15.3. Key Trends
15.4. Market Size (US$ Mn) Forecast, By Country
15.4.1. Saudi Arabia
15.4.2. South Africa
15.4.3. Rest of MEA
15.5. Market Size (US$ Mn) Forecast By Product Type
15.5.1. Devices
15.5.2.Disposables
15.6. Market Size (US$ Mn) Forecast, By Application
15.6.1. Renal diseases
15.6.2. Neurology
15.6.3. Hematology
15.6.4. Cancer
15.6.5. Autoimmune disease
15.6.6. Cardiovascular diseases
15.6.7. Others
15.7. Market Size (US$ Mn) Forecast By Procedure
15.7.1. Plasmapheresis
15.7.2. Photopheresis
15.7.3. LDL-apheresis
15.7.4. Plateletpheresis
15.7.5. Leukapheresis
15.7.6. Erythrocytapheresis
15.7.7. Others
15.8. Market Size (US$ Mn) Forecast, By Technology
15.8.1. Centrifugation
15.8.2. Membrane filtration
15.9. Market Size (US$ Mn) Forecast, By End User
15.9.1.Hospitals
15.9.2.Blood Collection Centers
15.9.2.1.Public
15.9.2.2.private
15.10. Market Attractiveness Analysis
15.10.1. By Country
15.10.2. By Product Type
15.10.3. By Application
15.10.4. By Procedure
15.10.5. By Technology
15.10.6. By End User
16.Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of companies)
16.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
16.2.1.Asahi Kasei Medical Co., Ltd.
16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.1.2. Product Portfolio
16.2.1.3. SWOT Analysis
16.2.1.4. Financial Overview
16.2.1.5. Strategic Overview
16.2.2. B. Braun Melsungen AG
16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.2.2. Product Portfolio
16.2.2.3. SWOT Analysis
16.2.2.4. Financial Overview
16.2.2.5. Strategic Overview
16.2.3. Cerus Corporation
16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.3.2. Product Portfolio
16.2.3.3. SWOT Analysis
16.2.3.4. Financial Overview
16.2.3.5. Strategic Overview
16.2.4. Fresenius Medical Care
16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.4.2. Product Portfolio
16.2.4.3. SWOT Analysis
16.2.4.4. Financial Overview
16.2.4.5. Strategic Overview
16.2.5. Haemonetics Corp.
16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.5.2. Product Portfolio
16.2.5.3. SWOT Analysis
16.2.5.4. Financial Overview
16.2.5.5. Strategic Overview
16.2.6. Hemacare Corporation
16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.6.2. Product Portfolio
16.2.6.3. SWOT Analysis
16.2.6.4. Financial Overview
16.2.6.5. Strategic Overview
16.2.7. Kawasumi Laboratories Inc.
16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.7.2. Product Portfolio
16.2.7.3. SWOT Analysis
16.2.7.4. Financial Overview
16.2.7.5. Strategic Overview
16.2.8. Medica S.p.A.
16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.8.2. Product Portfolio
16.2.8.3. SWOT Analysis
16.2.8.4. Financial Overview
16.2.8.5. Strategic Overview
16.2.9. NIKKISO CO., LTD.
16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.9.2. Product Portfolio
16.2.9.3. SWOT Analysis
16.2.9.4. Financial Overview
16.2.9.5. Strategic Overview
16.2.10. Terumo Corporation
16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.10.2. Product Portfolio
16.2.10.3. SWOT Analysis
16.2.10.4. Financial Overview
16.2.10.5. Strategic Overview
16.2.11. Therakos, Inc.
16.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.11.2. Product Portfolio
16.2.11.3. SWOT Analysis
16.2.11.4. Financial Overview
16.2.11.5. Strategic Overview
List of Tables:
Table 01: Global Apheresis Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 02: Global Apheresis Market Value (US$ Mn) Forecast, by Application, 2015–2025
Table 03: Global Apheresis Market Value (US$ Mn) Forecast, by Procedure, 2015–2025
Table 04: Global Apheresis Market Value (US$ Mn) Forecast, by Technology, 2015–2025
Table 05: Global Apheresis Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 06: Global Apheresis Market Value (US$ Mn) Forecast, by End-user (blood collection center), 2015–2025
Table 07: Global Apheresis Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 08: North America Apheresis Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 09: North America Apheresis Market Value (US$ Mn) Forecast, by Application, 2015–2025
Table 10: North America Apheresis Market Value (US$ Mn) Forecast, by Procedure, 2015–2025
Table 11: North America Apheresis Market Value (US$ Mn) Forecast, by Technology, 2015–2025
Table 12: North America Apheresis Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 13: North America Apheresis Market Value (US$ Mn) Forecast, by End-user (blood collection center), 2015–2025
Table 14: North America Apheresis Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 15: Europe Apheresis Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 16: Europe Apheresis Market Value (US$ Mn) Forecast, by Application, 2015–2025
Table 17: Europe Apheresis Market Value (US$ Mn) Forecast, by Procedure, 2015–2025
Table 18: Europe Apheresis Market Value (US$ Mn) Forecast, by Technology, 2015–2025
Table 19: Europe Apheresis Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 20: Europe Apheresis Market Value (US$ Mn) Forecast, by End-user (Blood Collection Centers), 2015–2025
Table 21: Europe Apheresis Market Value (US$ Mn) Forecast, by Country / Sub-region, 2015–2025
Table 22: Asia Pacific Apheresis Market Value (US$ Mn) Forecast, by Product, 2015–2025
Table 23: Asia Pacific Apheresis Market Value (US$ Mn) Forecast, by Application, 2015–2025
Table 24: Asia Pacific Apheresis Market Value (US$ Mn) Forecast, by Procedure, 2015–2025
Table 25: Asia Pacific Apheresis Market Value (US$ Mn) Forecast, by Technology, 2015–2025
Table 26: Asia Pacific Apheresis Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 27: Asia Pacific Apheresis Market Value (US$ Mn) Forecast, by End-user (Blood Collection Centers), 2015–2025
Table 28: Asia Pacific Apheresis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 29: Latin America Apheresis Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 30: Latin America Apheresis Market Value (US$ Mn) Forecast, by Application, 2015–2025
Table 31: Latin America Apheresis Market Value (US$ Mn) Forecast, by Procedure, 2015–2025
Table 32: Latin America Apheresis Market Value (US$ Mn) Forecast, by Technology, 2015–2025
Table 33: Latin America Apheresis Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 34: Latin America Apheresis Market Value (US$ Mn) Forecast, by End-user (Blood Collection Centers), 2015–2025
Table 35: Latin America Apheresis Market Value (US$ Mn) Forecast, by Country / Sub-region, 2015–2025
Table 36: Middle East & Africa Apheresis Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 37: Middle East & Africa Apheresis Market Value (US$ Mn) Forecast, by Application, 2015–2025
Table 38: Middle East & Africa Apheresis Market Value (US$ Mn) Forecast, by Procedure, 2015–2025
Table 39: Middle East & Africa Apheresis Market Value (US$ Mn) Forecast, by Technology, 2015–2025
Table 40: Middle East & Africa Apheresis Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 41: Middle East & Africa Apheresis Market Value (US$ Mn) Forecast, by End-user (blood collection center), 2015–2025
Table 42: Middle East & Africa Apheresis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
List of Figures:
Figure 01: Global Apheresis Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
Figure 02: Global Apheresis Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 03: Global Apheresis Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 04: Global Apheresis Disposables Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 05: Global Apheresis Market Attractiveness Analysis, by Product Type
Figure 06: Global Apheresis Market Value Share Analysis, by Application, 2016 and 2025
Figure 07: Global Apheresis in Renal Diseases Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 08: Global Apheresis in Neurology Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 09: Global Apheresis in Hematology Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 10: Global Apheresis in Cancer Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 11: Global Apheresis in Autoimmune Diseases Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 12: Global Apheresis in Cardiovascular Diseases Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 13: Global Apheresis in Other Applications Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 14: Global Apheresis Market Attractiveness Analysis, by Application
Figure 15: Global Apheresis Market Value Share Analysis, by Procedure, 2016 and 2025
Figure 16: Global Plasmapheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 17: Global Photopheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 18: Global LDL-Apheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 19: Global Plateletpheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 20: Global Leukapheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 21: Global Erythrocytapheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 22: Global Apheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other Procedures, 2015–2025
Figure 23: Global Apheresis Market Attractiveness Analysis, by Procedure
Figure 24: Global Apheresis Market Value Share Analysis, by Technology, 2016 and 2025
Figure 25: Global Centrifugation Apheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 26: Global Membrane Filtration Apheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 27: Global Apheresis Market Attractiveness Analysis, by Technology
Figure 28: Global Apheresis Market Value Share Analysis, by End-user, 2016 and 2025
Figure 29: Global Apheresis Market Value Share Analysis, by End-user (blood collection centers), 2016 and 2025
Figure 30: Global Hospitals Apheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 31: Global Blood Collection Centres Apheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 32: Global Private Blood Collection Centres Apheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 33: Global Public Blood Collection Centres Apheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 34: Global Apheresis Market Attractiveness Analysis, by End-user
Figure 35: Global Apheresis Market Value Share Analysis, by Region, 2016 and 2025
Figure 36: Global Apheresis Market Attractiveness Analysis, by Region
Figure 37: North America Apheresis Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
Figure 38: North America Market Attractiveness Analysis, by Country
Figure 39: North America Apheresis Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 40: North America Apheresis Market Value Share Analysis, by Application, 2016 and 2025
Figure 41: North America Apheresis Market Value Share Analysis, by Procedure, 2016 and 2025
Figure 42: North America Apheresis Market Value Share Analysis, by Technology, 2016 and 2025
Figure 43: North America Apheresis Market Value Share Analysis, by End-user, 2016 and 2025
Figure 44: North America Apheresis Market Value Share Analysis, by End-user (blood collection center), 2016 and 2025
Figure 45: North America Apheresis Market Value Share Analysis, by Country, 2016 and 2025
Figure 46: North America Apheresis Market Attractiveness Analysis, by Product Type
Figure 47: North America Apheresis Market Attractiveness Analysis, by Application
Figure 48: North America Apheresis Market Attractiveness Analysis, by Procedure
Figure 49: North America Apheresis Market Attractiveness Analysis, by Technology
Figure 50: North America Apheresis Market Attractiveness Analysis, by End-user
Figure 51: Europe Apheresis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection, 2017–2025
Figure 52: Europe Apheresis Market Attractiveness Analysis, by Country / Sub-region
Figure 53: Europe Apheresis Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 54: Europe Apheresis Market Value Share Analysis, by Application, 2016 and 2025
Figure 55: Europe Apheresis Market Value Share Analysis, by Procedure, 2016 and 2025
Figure 56: Europe Apheresis Market Value Share Analysis, by Technology, 2016 and 2025
Figure 57: Europe Apheresis Market Value Share Analysis, by End-user, 2016 and 2025
Figure 58: Europe Apheresis Market Value Share Analysis, by End-User (Blood Collection Centers), 2016 and 2025
Figure 59: Europe Apheresis Market Value Share Analysis, by Country / Sub-region, 2016 and 2025
Figure 60: Europe Apheresis Market Attractiveness Analysis, by Product
Figure 61: Europe Apheresis Market Attractiveness Analysis, by Application
Figure 62: Europe Apheresis Market Attractiveness Analysis, by Procedure
Figure 63: Europe Apheresis Market Attractiveness Analysis, by Technology
Figure 64: Europe Apheresis Market Attractiveness Analysis, by End-user
Figure 65: Asia Pacific Apheresis Market Size (US$ Mn) Forecast, 2017–2025
Figure 66: Asia Pacific Apheresis Market Attractiveness Analysis, by Country
Figure 67: Asia Pacific Apheresis Market Value Share Analysis, by Product, 2016 and 2025
Figure 68: Asia Pacific Apheresis Market Value Share Analysis, by Application, 2016 and 2025
Figure 69: Asia Pacific Apheresis Market Value Share Analysis, by Procedure, 2016 and 2025
Figure 70: Asia Pacific Apheresis Market Value Share Analysis, by Technology, 2016 and 2025
Figure 71: Asia Pacific Apheresis Market Value Share Analysis, by End-user, 2016 and 2025
Figure 72: Asia Pacific Apheresis Market Value Share Analysis, by End-user (Blood Collection Centers), 2016 and 2025
Figure 73: Asia Pacific Apheresis Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 74: Asia Pacific Apheresis Market Attractiveness Analysis, by Product
Figure 75: Asia Pacific Apheresis Market Attractiveness Analysis, by Application
Figure 76: Asia Pacific Apheresis Market Attractiveness Analysis, by Procedure
Figure 77: Asia Pacific Apheresis Market Attractiveness Analysis, by Technology
Figure 78: Asia Pacific Apheresis Market Attractiveness Analysis, by End-user
Figure 79: Latin America Apheresis Market Size (US$ Mn) Forecast, 2017–2025
Figure 80: Latin America Market Attractiveness Analysis, by Country / Sub-region
Figure 81: Latin America Apheresis Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 82: Latin America Apheresis Market Value Share Analysis, by Application, 2016 and 2025
Figure 83: Latin America Apheresis Market Value Share Analysis, by Procedure, 2016 and 2025
Figure 84: Latin America Apheresis Market Value Share Analysis, by Technology, 2016 and 2025
Figure 85: Latin America Apheresis Market Value Share Analysis, by End-user, 2016 and 2025
Figure 86: Latin America Apheresis Market Value Share Analysis, by End-user (Blood Collection Centers), 2016 and 2025
Figure 87: Latin America Apheresis Market Value Share Analysis, by Country / Sub-region, 2016 and 2025
Figure 88: Latin America Apheresis Market Attractiveness Analysis, by Product
Figure 89: Latin America Apheresis Market Attractiveness Analysis, by Application
Figure 90: Latin America Apheresis Market Attractiveness Analysis, by Procedure
Figure 91: Latin America Apheresis Market Attractiveness Analysis, by Technology
Figure 92: Latin America Apheresis Market Attractiveness Analysis, by End-user
Figure 93: Middle East & Africa Apheresis Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
Figure 94: Middle East & Africa Market Attractiveness Analysis, by Country/Sub-region
Figure 95: Middle East & Africa Apheresis Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 96: Middle East & Africa Apheresis Market Value Share Analysis, by Application, 2016 and 2025
Figure 97: Middle East & Africa Apheresis Market Value Share Analysis, by Procedure, 2016 and 2025
Figure 98: Middle East & Africa Apheresis Market Value Share Analysis, by Technology, 2016 and 2025
Figure 99: Middle East & Africa Apheresis Market Value Share Analysis, by End-user, 2016 and 2025
Figure 100: Middle East & Africa Apheresis Market Value Share Analysis, by End-user (blood collection center), 2016 and 2025
Figure 101: Middle East & Africa Apheresis Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 102: Middle East & Africa Apheresis Market Attractiveness Analysis, by Product Type
Figure 103: Middle East & Africa Apheresis Market Attractiveness Analysis, by Application
Figure 104: Middle East & Africa Apheresis Market Attractiveness Analysis, by Procedure
Figure 105: Middle East & Africa Apheresis Market Attractiveness Analysis, by Technology
Figure 106: Middle East & Africa Apheresis Market Attractiveness Analysis, by End-user
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
*86 figures and 60 tables includes